Viatris — Drug Prices & Medicare Spending
Viatris manufactures 2 drugs tracked by Medicare Part D with total spending of $579.0M.
2
Drugs Tracked
$579.0M
Medicare Spending
$133.41
Avg Cost/Claim
100%
Have Generics
Viatris Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Semglee | Insulin Glargine-yfgn | $139.00 | Yes |
| 2 | Wixela Inhub | Fluticasone/Salmeterol (generic) | $126.00 | Yes |
Frequently Asked Questions
Viatris manufactures 2 drugs tracked by Medicare Part D, with total annual spending of $579.0M.
Semglee (Insulin Glargine-yfgn) is the most expensive at $139.00 per claim.
2 of 2 Viatris drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.